{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:58:16Z","timestamp":1764331096797,"version":"3.40.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Pityriasis rosea Gibert is an erythematous-papulosquamous dermatosis that frequently occurs in young adults. The etiopathogenesis of PR is still unknown, but is frequently associated with episodes of upper respiratory tract infections. It is likely that a new viral trigger of pityriasis rosea is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We present the case of a female patient in whom the diagnosis of pityriasis rosea led to the investigation and diagnosis of the SARS-CoV-2 infection. The patient presented to the Department of Dermatology for a 3\u200aweek duration of an extremely pruritic erythematous-squamous lesion, initially on the trunk and upper limbs, with extension to the lower limbs in the last week and the lesion respected the cephalic extremity, palms, and soles. One week before the rash, respiratory tract infection symptomatology was observed by the patient. At home, she underwent systemic treatment with antihistamines and topical medication with dermatocorticosteroids. The evolution was unfavorable, with the spread of the lesions and the accentuation of the pruritus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Considering the actual epidemiological context, we performed a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay from nasal and pharyngeal swabs for coronavirus disease 2019 (COVID-19) to investigate the PR etiology. The patient had a positive RT-PCR result, and was confirmed with SARS-CoV-2 infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Treatment was initiated with systemic corticosteroid therapy - hydrocortisone hemisuccinate 200\u200amg\/day for 7\u200adays, and loratadine 10\u200amg 2 times a day. Also, topical medication with dermatocorticosteroids and emollients was associated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome:<\/jats:title>\n            <jats:p>Under the treatment that was initiated a partial remission of the lesions after 7\u200adays was observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Our reported case adds to the other findings regarding the association of PR with SARS-CoV-2 infection, in the context of the pandemic, suggesting the need to test patients with PR skin lesions for SARS-CoV-2 infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025352","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T04:51:33Z","timestamp":1617857493000},"page":"e25352","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Pityriasis rosea Gibert triggered by SARS-CoV-2 infection"],"prefix":"10.1097","volume":"100","author":[{"given":"Victoria","family":"Birlutiu","sequence":"first","affiliation":[{"name":"Lucian Blaga University of Sibiu, Faculty of Medicine Sibiu, Academic Emergency Hospital Sibiu - Infectious Diseases Clinic, Sibiu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-2904","authenticated-orcid":false,"given":"Rares Mircea","family":"Birlutiu","sequence":"additional","affiliation":[{"name":"Lucian Blaga University of Sibiu, Faculty of Medicine Sibiu, FOISOR Clinical Hospital of Orthopedics, Traumatology, and Osteoarticular TB Bucharest"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Mariana","family":"Iancu","sequence":"additional","affiliation":[{"name":"Lucian Blaga University of Sibiu, Faculty of Medicine Sibiu, Academic Emergency Hospital Sibiu - Dermatology Clinic, Sibiu, Romania."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1111\/jdv.16579","article-title":"Pytiriasis rosea as a cutaneous manifestation of COVID-19 infection","volume":"34","author":"Ehsani","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2230.2009.03469.x","article-title":"Characterization of the inflammatory cell infiltrate in herald patches and fully developed eruptions of pityriasis rosea","volume":"35","author":"Neoh","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.0022-202X.2005.23719.x","article-title":"Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7","volume":"124","author":"Broccolo","year":"2005","journal-title":"J Investig Dermatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0019-5154.185699","article-title":"Pityriasis rosea: An update on etiopathogenesis and management of difficult aspects","volume":"61","author":"Mahajan","year":"2016","journal-title":"Indian J Dermatol"},{"key":"R5-20250504","first-page":"e212","article-title":"Cutaneous manifestations in COVID-19: a first perspective","volume":"34:","author":"Recalcati","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 19 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e21810","DOI":"10.1097\/MD.0000000000021810","article-title":"Viral exanthema as manifestation of SARS-CoV-2 infection: a case report","volume":"99","author":"Iancu","year":"2020","journal-title":"Medicine"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2008.07.045","article-title":"Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology","volume":"61","author":"Drago","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1747.2002.00200.x","volume":"119","author":"Watanabe","year":"2002","journal-title":"Invest Dermatol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e13730","DOI":"10.1111\/dth.13730","article-title":"The clinics of HHV-6 infection in COVID-19 pandemic: pityriasis rosea and kawasaki disease","volume":"33","author":"Dursun","year":"2020","journal-title":"Dermatol Ther"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.medcli.2020.05.024","article-title":"Erupci\u00f3n tipo pitiriasis rosada de Gibert en una paciente asintom\u00e1tica con positividad para COVID-19","volume":"155","author":"Mart\u00edn Enguix","year":"2020","journal-title":"Med Clin (Barc)"},{"key":"R13-20250504","article-title":"Pityriasis rosea-like eruption revealing COVID-19","author":"Veraldi","year":"2020","journal-title":"Australas J Dermatol"},{"key":"R14-20250504","article-title":"Pityriasis rosea as a leading manifestation of COVID-19 infection","author":"Merhy","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdcr.2020.10.035","article-title":"Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: a report of 2 cases","volume":"7","author":"Johansen","year":"2020","journal-title":"JAAD Case Rep"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e237056","DOI":"10.1136\/bcr-2020-237056","article-title":"Prolonged dermatological manifestation 4\u200aweeks following recovery of COVID-19 in a child","volume":"13","author":"Ng","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.chom.2020.03.021","article-title":"A dynamic immune response shapes COVID-19 progression","volume":"27","author":"Ong","year":"2020","journal-title":"Cell Host Microbe"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:19:31Z","timestamp":1746339571000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025352"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":17,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025352","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"2021-01-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}